An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder
Version of Record online: 21 AUG 2007
Copyright © 2007 John Wiley & Sons, Ltd.
Human Psychopharmacology: Clinical and Experimental
Volume 22, Issue 7, pages 455–462, October 2007
How to Cite
Centorrino, F., Meyers, A. L., Ahl, J., Cincotta, S. L., Zun, L., Gulliver, A. H., Kinon, B. J. and Houston, J. P. (2007), An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder. Hum. Psychopharmacol. Clin. Exp., 22: 455–462. doi: 10.1002/hup.870
- Issue online: 25 SEP 2007
- Version of Record online: 21 AUG 2007
- Manuscript Accepted: 10 JUL 2007
- Manuscript Received: 5 FEB 2007
- Eli Lilly and Company
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.